KRAS-driven cytokine-metabolic crosstalk shapes immune exclusion in pancreatic ductal adenocarcinoma.

KRAS mutations in pancreatic ductal adenocarcinoma drive cytokine and metabolic crosstalk that causes immune exclusion, with key pathways involving STAT3, NF-κB, HIF-1α, and MYC.

• Why it matters: Understanding how KRAS mutations shape the tumor microenvironment is crucial because PDAC is highly resistant to immunotherapy due to immune exclusion, limiting treatment options.
• What they did: The study reviews evidence that mutant KRAS alters cytokine secretion and metabolic processes, such as glycolysis and lactate buildup, which promote immunosuppressive cell accumulation and stromal barriers, involving several regulatory nodes.
• The result: This crosstalk creates a spatial immune exclusion, suggesting that targeting these interconnected pathways could improve immunotherapy responses in PDAC patients.